Loading...
Novel and emerging therapies for the treatment of polycythemia vera
Polycythemia vera (PV) is a chronic myeloproliferative neoplasm defined by erythrocytosis and often accompanied by leukocytosis and thrombocytosis. Current treatment options, including IFN-α and hydroxyurea, effectively manage PV in many patients. However, some high-risk patients, particularly those...
Na minha lista:
| Udgivet i: | Expert Rev Hematol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4934659/ https://ncbi.nlm.nih.gov/pubmed/25353086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17474086.2015.972359 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|